- Home
- IPA vs AMS Comparison
IPA vs AMS Comparison
Compare IPA & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- AMS
- Stock Information
- Founded
- IPA 1983
- AMS 1980
- Country
- IPA Canada
- AMS United States
- Employees
- IPA N/A
- AMS 13
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- IPA Health Care
- AMS Health Care
- Exchange
- IPA Nasdaq
- AMS Nasdaq
- Market Cap
- IPA 19.3M
- AMS 19.3M
- IPO Year
- IPA 2017
- AMS N/A
- Fundamental
- Price
- IPA $0.39
- AMS $3.01
- Analyst Decision
- IPA Strong Buy
- AMS
- Analyst Count
- IPA 2
- AMS 0
- Target Price
- IPA $5.00
- AMS N/A
- AVG Volume (30 Days)
- IPA 1.3M
- AMS 4.3K
- Earning Date
- IPA 03-13-2025
- AMS 03-26-2025
- Dividend Yield
- IPA N/A
- AMS N/A
- EPS Growth
- IPA N/A
- AMS 779.12
- EPS
- IPA N/A
- AMS 0.61
- Revenue
- IPA $17,272,336.00
- AMS $24,969,000.00
- Revenue This Year
- IPA $1.88
- AMS $27.74
- Revenue Next Year
- IPA $9.90
- AMS $17.72
- P/E Ratio
- IPA N/A
- AMS $4.96
- Revenue Growth
- IPA 6.36
- AMS 20.83
- 52 Week Low
- IPA $0.33
- AMS $2.51
- 52 Week High
- IPA $2.43
- AMS $4.60
- Technical
- Relative Strength Index (RSI)
- IPA 36.66
- AMS 45.88
- Support Level
- IPA $0.43
- AMS $2.88
- Resistance Level
- IPA $0.53
- AMS $3.10
- Average True Range (ATR)
- IPA 0.04
- AMS 0.06
- MACD
- IPA -0.01
- AMS -0.01
- Stochastic Oscillator
- IPA 8.42
- AMS 40.33
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.